Results 91 to 100 of about 143,652 (302)

An Economic Evaluation of Direct Oral Penicillin Challenge for De‐Labelling Low Risk Patients With a Penicillin Allergy Label

open access: yesClinical &Experimental Allergy, Volume 55, Issue 5, Page 378-390, May 2025.
The cost of the Direct Oral Penicillin Challenge (DPC) itself is only a fraction of the full costs required to test for a penicillin allergy label by non‐allergists. The costs of DPC varied between hospitals using a nurse‐led, pharmacist‐led, or mixture of pharmacists and nurses.
R. Bestwick   +10 more
wiley   +1 more source

Cost-effectiveness of different MRSA screening methods.

open access: yes, 2002
We describe a model to examine the cost-effectiveness of various laboratory-screening approaches to detect methicillin-resistant Staphylococcus aureus (MRSA).
Cookson, B   +4 more
core   +1 more source

Meningococcal Vaccines: Current Status and Emerging Strategies

open access: yesVaccines, 2018
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy   +2 more
doaj   +1 more source

A Systematic Review of Cases of Meningitis in the Absence of Cerebrospinal Fluid Pleocytosis on Lumbar Puncture [PDF]

open access: yes, 2019
Background: Definitive diagnosis of meningitis is made by analysis of cerebrospinal fluid (CSF) culture or polymerase chain reaction (PCR) obtained from a lumbar puncture (LP), which may take days.
Pettigrew, Alexis, Troendle, Michelle
core   +1 more source

Meningitis and meningococcal septicaemia [PDF]

open access: yesArchives of Disease in Childhood, 2000
Editor,—In May 1999, prior to the meningococcal C campaign, we designed a questionnaire to ascertain knowledge about meningitis and meningococcal septicaemia among 15/16 year olds. Groups of 8–10 volunteers, in each of the local state secondary schools in Bath, independently completed a short questionnaire. The school nurse then led a tutorial session,
Rosemary Jones   +3 more
openaire   +2 more sources

Long‐Term Efficacy and Safety of Ravulizumab in Adults With Anti‐Acetylcholine Receptor Antibody‐Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open‐Label Extension

open access: yesEuropean Journal of Neurology, Volume 32, Issue 4, April 2025.
Ravulizumab demonstrated clinically meaningful and durable efficacy and safety in adults with anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis in the CHAMPION MG open‐label extension (OLE) study. Improvements from baseline in MG‐ADL, QMG, and MG‐QOL15r total scores, and the NeuroQOL Fatigue subscale scores achieved in ...
Tuan H. Vu   +10 more
wiley   +1 more source

Vaccine implementation: Alaska 2017 [PDF]

open access: yes, 2017
Bacterial meningitis is a serious disease that causes permanent dysfunction or death; adolescents and young adults carry the greatest risk. The national Advisory Committee on Immunization Practices (ACIP) has released vaccine recommendations that include
Hulstine, Amanda
core  

Impact of serogroup A meningococcal conjugate vaccine for Africa

open access: yesHuman Vaccines & Immunotherapeutics, 2018
The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated ...
James M. Stuart
doaj   +1 more source

Two New Kindreds with Complete Factor D Deficiency

open access: yesEuropean Journal of Immunology, Volume 55, Issue 3, March 2025.
The complement system plays a crucial role in immune defense, and factor D deficiency is a rare immunodeficiency associated with life‐threatening bacterial infections. We report two new cases of complete factor D deficiency, including the first described in a Down syndrome patient, highlighting the need to investigate complement deficiencies in ...
Mathilde Puel   +10 more
wiley   +1 more source

Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175) Neisseria meningitidis clone in the African meningitis belt. [PDF]

open access: yes, 2017
Countries of the African 'meningitis belt' are susceptible to meningococcal meningitis outbreaks. While in the past major epidemics have been primarily caused by serogroup A meningococci, W strains are currently responsible for most of the cases.
Abdul Sater, Mohamad R   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy